Vertex Pharmaceuticals Inc (VRTX): Operating Income
$4.17B
Year ended 2025-12-31
$4.78B
Trailing 12 months to 2026-06-30
-1.0%
3-year compound annual growth
+7.9%
5-year compound annual growth
| Period ended | Operating Income | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $4.17B | n/m | 2026-02-13, From 2025-01-01 |
| 2024-12-31 | -$232.90M | n/m | 2026-02-13, From 2024-01-01 |
| 2023-12-31 | $3.83B | -11.0% | 2026-02-13, From 2023-01-01 |
| 2022-12-31 | $4.31B | +54.8% | 2025-02-13, From 2022-01-01 |
| 2021-12-31 | $2.78B | -2.6% | 2024-02-15, From 2021-01-01 |
| 2020-12-31 | $2.86B | +138.5% | 2023-02-10, From 2020-01-01 |
| 2019-12-31 | $1.20B | +88.5% | 2022-02-09, From 2019-01-01 |
| 2018-12-31 | $635.15M | +415.4% | 2021-02-11, From 2018-01-01 |
| 2017-12-31 | $123.24M | n/m | 2020-02-13, From 2017-01-01 |
| 2016-12-31 | $9.94M | n/m | 2019-02-13, From 2016-01-01 |
| 2015-12-31 | -$466.88M | n/m | 2018-02-15, From 2015-01-01 |
| 2014-12-31 | -$692.41M | n/m | 2017-02-23, From 2014-01-01 |
| 2013-12-31 | -$610.01M | n/m | 2016-02-16, From 2013-01-01 |
| 2012-12-31 | $46.73M | -58.9% | 2015-02-13, From 2012-01-01 |
| 2011-12-31 | $113.82M | n/m | 2014-02-11, From 2011-01-01 |
| 2010-12-31 | -$696.08M | n/m | 2013-03-01, From 2010-01-01 |
| 2009-12-31 | -$614.01M | n/m | 2012-02-22, From 2009-01-01 |
| 2008-12-31 | -$462.71M | n/a | 2011-02-17, From 2008-01-01 |
Operating Income at similar companies
| Company | Year ended | Operating Income | Change YoY |
|---|---|---|---|
| Vertex Pharmaceuticals Inc (VRTX) | 2025-12-31 | $4.17B | n/m |
| Bausch Health Companies Inc. (BHC) | 2025-12-31 | $1.81B | +17.3% |
| Viatris Inc (VTRS) | 2025-12-31 | -$2.66B | n/m |
| Regeneron Pharmaceuticals, Inc. (REGN) | 2025-12-31 | $3.58B | -10.3% |
| Teva Pharmaceutical Industries Ltd (TEVA) | 2025-12-31 | $2.16B | n/m |
| BeOne Medicines Ltd. (ONC) | 2025-12-31 | $447.14M | n/m |
| Jazz Pharmaceuticals plc (JAZZ) | 2025-12-31 | -$430.24M | n/m |
| Perrigo Co PLC (PRGO) | 2025-12-31 | -$1.12B | n/m |
| Alnylam Pharmaceuticals, Inc. (ALNY) | 2025-12-31 | $501.58M | n/m |
Compare VRTX, BHC, VTRS, REGN side by side · Screen every company in Pharmaceutical Preparations ↗